These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8821523)

  • 21. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
    Burai L; Tóth E; Sour A; Merbach AE
    Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicological assessment of gadolinium release from contrast media.
    Bussi S; Fouillet X; Morisetti A
    Exp Toxicol Pathol; 2007 Apr; 58(5):323-30. PubMed ID: 17150343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat.
    Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Schitt-Willich H [corrected to Schmitt-Willich H]
    J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats.
    Boyken J; Frenzel T; Lohrke J; Jost G; Schütz G; Pietsch H
    Invest Radiol; 2019 Feb; 54(2):76-82. PubMed ID: 30358694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand.
    Sieber MA; Lengsfeld P; Walter J; Schirmer H; Frenzel T; Siegmund F; Weinmann HJ; Pietsch H
    J Magn Reson Imaging; 2008 May; 27(5):955-62. PubMed ID: 18425843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
    Yan GP; Hu B; Liu ML; Li LY
    J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of dysprosium in monkey serum by inductively-coupled plasma atomic emission spectrometry (ICP-AES) after the administration of Sprodiamide Injection, a new contrast medium for magnetic resonance imaging.
    Lai JJ; Jamieson GC
    J Pharm Biomed Anal; 1993; 11(11-12):1129-34. PubMed ID: 8123724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dy-EOB-DTPA: tolerance and pharmacokinetics in healthy volunteers and preliminary liver imaging in patients.
    Krause W; Mahler M; Hanke B; Milius W; Kaufmann J; Rogalla P; Hamm B
    Invest Radiol; 2001 Aug; 36(8):431-44. PubMed ID: 11500593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity.
    Parac-Vogt TN; Kimpe K; Laurent S; Vander Elst L; Burtea C; Chen F; Muller RN; Ni Y; Verbruggen A; Binnemans K
    Chemistry; 2005 May; 11(10):3077-86. PubMed ID: 15776492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the role of zinc in the occurrence of fibrosis of the skin: a preclinical study.
    Pietsch H; Pering C; Lengsfeld P; Walter J; Steger-Hartmann T; Golfier S; Frenzel T; Hütter J; Weinmann HJ; Sieber MA
    J Magn Reson Imaging; 2009 Aug; 30(2):374-83. PubMed ID: 19629978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of gadolinium(III) complexes in biological tissue extracts.
    Kahakachchi CL; Moore DA
    Metallomics; 2010 Jul; 2(7):490-7. PubMed ID: 21072349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy.
    White GW; Gibby WA; Tweedle MF
    Invest Radiol; 2006 Mar; 41(3):272-8. PubMed ID: 16481910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preparation of a novel targeted MR contrast agent Gd-DTPA-streptavidin and exploration of its reaction conditions].
    Liu X; Xu YK; Huang QL
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):15-7. PubMed ID: 14724085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadodiamide in renal transplant patients: effects on renal function and usefulness as a glomerular filtration rate marker.
    Berg KJ; Lundby B; Reinton V; Nordal KP; Rootwelt K; Smith HJ
    Nephron; 1996; 72(2):212-7. PubMed ID: 8684529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complexation properties of the ligand EOB-DTPA and the kinetic stability of Gd(EOB-DTPA)].
    Burai L; Brücher E; Király R; Solymosi P; Víg T
    Acta Pharm Hung; 2000; 70(3-6):89-96. PubMed ID: 11379036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of Gd-DTPA in patients with chronic renal failure.
    Schuhmann-Giampieri G; Krestin G
    Invest Radiol; 1991 Nov; 26(11):975-9. PubMed ID: 1743921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.
    Kiessling F; Heilmann M; Lammers T; Ulbrich K; Subr V; Peschke P; Waengler B; Mier W; Schrenk HH; Bock M; Schad L; Semmler W
    Bioconjug Chem; 2006; 17(1):42-51. PubMed ID: 16417250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.